APA

Takada M., Fukuoka M., Ariyoshi Y., Furuse K., Niitani H., Ota K., Motomiya M., Hasegawa K., Tominaga K. & Kuriyama T. (19930119). The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. : Cancer chemotherapy and pharmacology.

Chicago

Takada M, Fukuoka M, Ariyoshi Y, Furuse K, Niitani H, Ota K, Motomiya M, Hasegawa K, Tominaga K and Kuriyama T. 19930119. The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. : Cancer chemotherapy and pharmacology.

Harvard

Takada M., Fukuoka M., Ariyoshi Y., Furuse K., Niitani H., Ota K., Motomiya M., Hasegawa K., Tominaga K. and Kuriyama T. (19930119). The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. : Cancer chemotherapy and pharmacology.

MLA

Takada M, Fukuoka M, Ariyoshi Y, Furuse K, Niitani H, Ota K, Motomiya M, Hasegawa K, Tominaga K and Kuriyama T. The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. : Cancer chemotherapy and pharmacology. 19930119.